Social Media Ideas for Aquestive

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Aquestive resubmits its Anaphylm NDA after completing additional human factors and pharmacokinetic studies requested by the FDA. The post Aquestive Resubmits Needle-Free Sublingual...

Axsome rises on Auvelity prescription data

An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slide

Alkermes’ results heightened anticipation for a coming readout in 2027. Elsewhere, AbbVie leaned into AI drug discovery and the FDA expanded use of Eli Lilly’s breast cancer pill.

Aquestive Therapeutics moves R&D to HELIX in New Brunswick

The HELIX in downtown New Brunswick is maintaining momentum in October, announcing Aquestive Therapeutics Inc. has moved its research & development operations to the transforma...

<![CDATA[The Next Chapter in Metabolic Drug Development]]>

<![CDATA[Beyond Amyloid, Part Two (of two): Delivery, Diagnostics and the Path to Combination Care]]>

SpicyIP Tidbit: Putting the Cart Before the Horse: A Look into Esteve Pharmaceuticals vs CPD

In the August 7 order passed in Esteve Pharmaceuticals S.A. vs Controller of Patents and Designs (2026), the Delhi High Court adopted a tiered approach in examining the grounds for...